biosurgery

Also found in: Dictionary.

Orthopedics An emerging field that utilizes enabling biomaterial, therapeutic, and sophisticated device technologies to improve the health of patients in the orthopedics and post-surgical adhesive disease areas
Wound care Maggot debridement therapy

biosurgery

The use of live sterile maggots to clean up and disinfect infected wounds.

Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005

References in periodicals archive ?

Genzyme Biosurgery has an extensive portfolio of biotechnology products in development for the treatment of heart disease.

Genzyme Biosurgery, Excigen collaborate in developing gene therapy for cardiac arrhythmia

"This transaction delivers significant value to our shareholders and allows us to combine our portfolio of orthobiologic and biosurgery products as well as our proprietary biomaterials pipeline with Stryker's sales and marketing teams.

Stryker continues spending spree with purchase of Orthovita

Genzyme Biosurgery, One Kendall Square, Cambridge, MA 02139.

Surgical/Hernia Mesh & Fixation Products

Before joining Macrocure, Lankry was the finance director at Omrix Biopharmaceuticals, Ltd., a division of Ethicon Biosurgery, a Johnson and Johnson company.

Gamida Cell Names Shai Lankry as CFO

Previously, Koblish was employed as president and CEO of Orthovita, a publicly traded orthobiologics and biosurgery medical device company.

Cerapedics elects board member, board chair & to exhibit at North American Spine Society 2017 annual meeting

[USPRwire, Thu Dec 11 2014] Global Markets Direct's, 'Kuros Biosurgery AG - Product Pipeline Review - 2014', provides an overview of the Kuros Biosurgery AG's pharmaceutical research and development focus.

"Kuros Biosurgery AG - Product Pipeline Review - 2014" is now available at Fast Market Research

The medical products business, with a portfolio of intravenous (IV) solutions, nutritional therapies, drug delivery systems, administration sets, premixed and other injectable drugs, as well as inhalation anesthetics and hospital-based biosurgery products, will keep the Baxter International name, continue under its current chairman and CEO Robert L Parkinson Jr.

Baxter Intl unveils split plan

"This transaction allows us to combine our portfolio of orthobiologic and biosurgery products as well as our proprietary biomaterials pipeline with Stryker's sales and marketing teams.

Stryker purchases Orthovita

Prior to Hologic, Densel held senior management roles at Natick, Mass.-based medical device maker Boston Scientific and Cambridge, Mass.-based Genzyme Biosurgery, which develops product lines for osteoarthritis relief, adhesion prevention, cartilage repair and severe burn treatment.

Dune Medical Devices appoints president, U.S., and CBO

This growth was driven by record sales of ADVATE, Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (rAHF-PFM) for the treatment of hemophilia A, antibody therapy products, including GAMMAGARD LIQUID(TM) [Immune Globulin Intravenous (Human)] (IVIG) 10% Solution for the treatment of primary immunodeficiencies, specialty plasma therapeutics and biosurgery products.

BAXTER'S ACHIEVED RECORD SALES/EARNINGS IN 2006

is engaged in the discovery and development of biosurgery and pharmaceutical products.

Gliatech receives allowance of United States patent claiming therapeutic antibodies to properdin

Previously, Toselli served five years at Sanofi in various levels of increasing responsibility, including vice president of global medical affairs Immunology and Inflammation, Biologics Division; vice president of global medical affairs and head of the Biosurgery Discovery Performance Unit; and vice president of global medical affairs, biosurgery.